Cubist Systematic Strategies, LLC Design Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.23 - $4.77 $32,664 - $48,239	10,113 Added 75.56%	23,497 $78,000
Q1 2024 May 15, 2024	SELL	$2.27 - $4.03 $100,554 - $178,516	-44,297 Reduced 76.8%	13,384 $53,000
Q4 2023 Feb 14, 2024	BUY	$1.99 - $2.76 $61,180 - $84,853	30,744 Added 114.13%	57,681 $152,000
Q3 2023 Nov 14, 2023	SELL	$2.05 - $8.14 $81,485 - $323,556	-39,749 Reduced 59.61%	26,937 $63,000
Q2 2023 Aug 14, 2023	SELL	$4.99 - $7.64 $556,874 - $852,608	-111,598 Reduced 62.6%	66,686 $420,000
Q1 2023 May 15, 2023	BUY	$5.5 - $9.77 $379,395 - $673,944	68,981 Added 63.11%	178,284 $1.03 Million
Q4 2022 Feb 14, 2023	BUY	$7.86 - $17.2 $859,121 - $1.88 Million	109,303 New	109,303 $1.12 Million

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $252M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.